Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luvadaxistat Pharmacodynamics in Schizophrenia
NCT03359785Phase 2Completed
- Sponsor
- Neurocrine Biosciences
- Start
- Jan 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of luvadaxistat in schizophrenia, sponsored by Neurocrine Biosciences. Started Jan 2018; status: completed.
02
Drugs
luvadaxistat
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT03359785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03359785.